Solamargine Inhibits the Development of Hypopharyngeal Squamous Cell Carcinoma by Decreasing LncRNA HOXA11-As Expression

Hypopharyngeal squamous cell carcinoma (HSCC) is one of the high mortality cancers with a poor prognosis, which is driving the development of new chemotherapeutic agents. We identified the anticancer effects of a natural compound, solamargine (SM), on FaDU cells and explored its mechanism in terms o...

詳細記述

書誌詳細

出版年:	Frontiers in Pharmacology
主要な著者:	Ying Meng, Mengli Jin, Dai Yuan, Yicheng Zhao, Xiangri Kong, Xuerui Guo, Xingye Wang, Juan Hou, Bingmei Wang, Wu Song, Yong Tang
フォーマット:	論文
言語:	英語
出版事項:	Frontiers Media S.A. 2022-07-01
主題:	solamargine hypopharyngeal squamous cell carcinoma HOXA11-AS miR-155 c-Myc
オンライン･アクセス:	https://www.frontiersin.org/articles/10.3389/fphar.2022.887387/full